Kim TM, Yoo JS, Moon HW, Hur KJ, et al. Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up. BMC Cancer 2020;20:1203.
PMID: 33287735